Professor Robert A Hegele - The new genetics & therapies of dyslipidemias
Professor Robert A Hegele - The new genetics & therapies of dyslipidemias - summary presentation
Видео Professor Robert A Hegele - The new genetics & therapies of dyslipidemias канала At the Limits - Leading Medical Education
Видео Professor Robert A Hegele - The new genetics & therapies of dyslipidemias канала At the Limits - Leading Medical Education
Показать
Комментарии отсутствуют
Информация о видео
2 марта 2021 г. 15:09:38
00:08:51
Другие видео канала
Professor Malcolm K Brenner - Overview of cell therapy for cancer in 2022 and beyondDr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond - full presentationDr Sarita Naik - The management of diabetes in elderly patients with multiple co-morbiditiesDr Gabrielle De Luca - The pathology of secondary progressive MSDr Marc Pfeffer - HFpEF: looking back - forging forward - Full versionProfessor Jeremy Chataway - Octopus - inside the progressive MS mega-trialDr Ellen Mowry - Diet and MS courseProfessor Mansoor Husain - GLP-1 analogues - have the limits been reached? - Full versionProfessor Basil Sharrack and Professor John Snowden - AHSCT and the management of MSProfessor Sean Wharton - The science of obesity, where might this lead clinical practice?Professor Christopher Wilcox - Diuretic resistance - new tricks for an old problem - Full versionProfessor John Deanfield - Cardiologia primordial na juventude – quais são os limites?Miranda Olding - The value of nurse prescribing in the management of people with MSDebate a new era in the management of type 2 diabetes & cardiorenal diseaseProfessor Karl S Peggs - Tumour neoantigens – the next frontier?Professor Marc Pfeffer - Surprising findings from clinical trials – cardio, diabetes & nephrologyDr Laura Piccio - Immunological effect of caloric restriction in MS and EAEDr Jennifer Graves - The effect of biological age on disease progressionProfessor Karen Sliwa - 'Cardiovascular & renal complications in pregnancy: cardiovascular'Dr Emma Tallantyre - DMT management – where disease biology and treatment algorithms meet (or not!)